Company Overview
SILEXION THERAPEUTICS CORP
SLXNRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
—M
2025 FY
Net Income
-12M
2025 FY
Shares Outstanding
1M
2025 FY
EPS
8.96USD
2025 FY
Company Information
SIC Code
2836
CIK Code
2022416
Exchange
Nasdaq
Location
IL